Background-Atrial natriuretic peptide (ANP) depresses contractility in left ventricular myocytes. Its expression is upregulated in pressure-overloaded hypertrophied hearts; however, the effects of ANP on contractility in hypertrophied myocytes are not known. Our aims were (1) to examine the cellular mechanisms of this depression in contractility in normal myocytes and (2) to test the hypothesis that the effects of ANP on contractility differ in hypertrophied myocytes from rats with ascending aortic stenosis. Methods and Results-We measured the myocyte shortening as an index of contractility, [Ca 2ϩ ] i with fluo 3, and pH i with seminaphthorhodafluor-1 (SNARF-1). In normal control myocytes (nϭ26), ANP caused a concentration-dependent depression of contractility and reduction in pH i . In the presence of 10 Ϫ6 mol/L ANP, fractional cell shortening was 78Ϯ5% of baseline (PϽ0.05) and pH i was reduced by 0.16Ϯ0.04 U from baseline (PϽ0.01) without changes in [Ca 2ϩ ] i . The magnitude of the depression of contraction caused by ANP was similar to that caused by intracellular acidification induced by an NH 4 Cl pulse. The effects of ANP on contractility and pH i were prevented in the presence of 5-(N-ethyl-N-isopropyl)-amiloride (EIPA), which inhibits the Na ϩ /H ϩ exchanger. In hypertrophied myocytes (nϭ23), ANP did not depress either myocyte contractility or pH i at concentrations of either 10 Ϫ8 , 10 Ϫ7 , or 10 Ϫ6 mol/L. ANP caused no change in pH i or the [Ca 2ϩ ] i transient in hypertrophied myocytes. The cGMP level was increased and Na ϩ /H
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ANP is expressed in the myocardium during fetal heart development 4 and reexpressed in the left ventricle (LV) in response to pressure overload in adult hypertrophied hearts. 5, 6 However, the effect of ANP on myocardial function in hypertrophied myocytes characterized by chronic basal upregulation of ANP synthesis has not yet been examined. Our purposes in this study were (1) to identify the mechanism of depression of contraction by ANP in normal myocytes and (2) to examine the effects of ANP on hypertrophied myocytes from rats with chronic aortic stenosis, in which we have demonstrated upregulation of LV ANP in the development of hypertrophy. 6 Because ANP could potentially affect contractility by changing [Ca 2ϩ ] i homeostasis or by changing intracellular pH to alter the myofilament sensitivity to [Ca 2ϩ ] i , 7, 8 we measured pH i and [Ca 2ϩ ] i in isolated control and hypertrophied myocytes challenged by ANP. In this study, we determined that ANP depressed myocyte contractility by promoting intracellular acidification in normal myocytes; in contrast, ANP failed to depress either contractility or pH i in hypertrophied myocytes.
Methods
Weanling male Wistar rats (Charles River Breeding Laboratories, Raleigh, NC) underwent ascending aortic banding (nϭ12) to make an aortic stenosis or a sham operation (nϭ24) at the age of 3 to 4 weeks. We have previously shown that this aortic stenosis rat model is characterized by concentric LV hypertrophy, the absence of chamber dilatation, and preserved ejection fraction. 6,9,10 At 9 to 11 weeks after the surgery, after closed-chest LV pressure was recorded, the animals were euthanized and LV myocytes were prepared with collagenase perfusion by a method described previously. [11] [12] [13] [14] Myocyte [Ca 2ϩ ] i was measured with fluo 3 (Molecular Probes, Inc) with an excitation wave length of 480Ϯ20 nm and emission signal detected at 535Ϯ25 nm. The optical system and calibration method for [Ca 2ϩ ] i are described in detail elsewhere. [11] [12] [13] [14] The pH i was measured with seminaphthorhodafluor-1 (SNARF 1-AM) (Molecular Probes, Inc) with an excitation wave length of 540 nm and emission signal detected at 580 and 640 nm. 12, 13 The pH i for each cell was calibrated in situ by exposing cells to solutions of varying pH and was calculated by the method previously described. 12, 13 At baseline, myocytes were superfused with oxygenated HEPESbuffered Tyrode's solution. 11, 14 The myocytes were maintained at 37°C and were paced at 0.5 Hz. To identify the intracellular mechanisms, cell motion and pH i were measured in control myocytes superfused with the HEPES-buffered solution containing 10 Ϫ8 , 10
Ϫ7
, and 10
Ϫ6 mol/L of ANP (27-amino-acid synthetic ANP, Sigma). Each ANP concentration was studied in a separate group of myocytes (7 to 10 cells per group) in steady state for 10 minutes. After the observation that ANP caused intracellular acidification in control myocytes, myocytes were superfused with 10 Ϫ6 mol/L ANP in the presence of 10 Ϫ5 mol/L 5-(N-ethyl-N-isopropyl)-amiloride (EIPA, Sigma) to assess the contribution of Na ϩ /H ϩ exchange in ANPinduced acidification. After the baseline measurement and 6 minutes of exposure to 10 Ϫ5 mol/L EIPA, the cell motion and pH i were measured in the separate groups of myocytes (nϭ6 cells per group) 6 minutes after 10 Ϫ6 mol/L ANP exposure in the presence of EIPA. To examine the effects of ANP on hypertrophied myocytes, cell motion was measured in HEPES-buffered solution containing 10 Ϫ8 , 10 To identify potential biochemical changes in ANP signaling, cGMP levels and Na ϩ /H ϩ exchanger mRNA levels were measured in LVs from additional control (nϭ12) and aortic stenosis rats (nϭ14). The LV tissues were frozen in liquid nitrogen and homogenized, and cGMP was measured by enzyme immunoassay with a commercially available kit (Amersham Life Science). The methods of total RNA extraction and Northern blot analysis were described in detail elsewhere 6 and used a probe of cDNA fragment encoding the Na ϩ /H ϩ exchanger provided by Dr John Orlowski. The message levels were normalized to those of GAPDH.
Two-way ANOVA with repeated measures was used to compare the values measured in response to exposure to ANP for control and hypertrophied myocytes. An unpaired Student's t test was used for comparisons of body and LV weights, in vivo LV pressure, and baseline myocyte characteristics between the groups. A probability value of PϽ0.05 was considered significant. Results are expressed as meanϮSEM.
Results
The in vivo parameters of LV function and baseline function of LV myocytes are shown in the Table. The LV weight and ratio of LV weight to body weight were significantly increased in aortic stenosis rats. LV systolic pressure and LV developed pressure per unit mass were significantly increased in aortic stenosis rats at this stage of compensatory hypertrophy compared with controls. Diastolic myocyte length was slightly increased in hypertrophied myocytes compared with controls. Consistent with the in vivo LV performance indices, fractional cell shortening was increased in the hypertrophied myocytes. The systolic and diastolic [Ca 2ϩ ] i values and pH i at baseline were similar in hypertrophied and control myocytes.
As shown in Figure 1 , left, ANP caused a concentrationdependent reduction of cell shortening in control myocytes. In response to 10 Ϫ6 mol/L ANP, myocyte fractional shorten- 4 Cl pulse, as we recently reported. 13 Our data with 10
Ϫ6
mol/L ANP challenge were similar to the relationships between pH i and fractional shortening during acidification caused by NH 4 Cl in normal myocytes ( Figure 2 ). This indicates that the depression of contraction by ANP is similar in magnitude to the depression of contractility when acute intracellular acidification is induced by the differing mechanism of an NH 4 Cl challenge. In the presence of blockade of Na ϩ /H ϩ exchange by 10 Ϫ5 mol/L EIPA, 10 Ϫ6 mol/L ANP failed to cause either depression of contraction (94Ϯ1% of baseline, PϭNS) or intracellular acidification (⌬0.01Ϯ0.02 U, PϭNS) in control myocytes.
In contrast with the effects of ANP in normal myocytes, ANP failed to cause either a depression of myocyte fractional shortening or intracellular acidification in hypertrophied myocytes at any concentration examined (fractional shortening, % of baseline: 10 Ϫ8 mol/L, 96Ϯ5%, PϭNS; 10 Ϫ7 mol/L, 97Ϯ9%, PϭNS; and 10
Ϫ6 mol/L, 101Ϯ10%, PϭNS). As summarized in Figure  3 , with ANP 10 Ϫ6 mol/L challenge, intracellular pH was also not depressed in hypertrophied myocytes. There was no effect of 10 Ϫ6 mol/L ANP on either peak systolic or diastolic [Ca 2ϩ ] i in the hypertrophied myocytes.
cGMP level was significantly higher in LVs from aortic stenosis rats (nϭ9) than in control rats (nϭ7) (411.9Ϯ86.4 versus 763.1Ϯ115.1 pmol/g protein, PϽ0.05), indicating enhanced steady-state production of LV cGMP, at least partly via upregulated ANP. The mRNA level of Na ϩ /H ϩ exchanger was similar in LVs of rats from the control (nϭ5) and the aortic stenosis (nϭ5) rats (1.0Ϯ0.3 versus 0.5Ϯ0.1 densitometric units, PϭNS).
Discussion
The immediate administration of ANP has been reported to depress contractility of freshly isolated myocytes 2 and ven- Ϫ6 mol/L ANP in normal (control) and hypertrophied myocytes. In contrast to response of normal myocytes, ANP failed to depress fractional shortening (top) or depress pH i (bottom) in hypertrophied myocytes. tricular papillary muscle. 3 Our finding of the concentrationdependent negative inotropic effects of ANP examined in normal myocytes is consistent with these studies. The concentration of ANP examined in our study was higher than the steady-state concentration in normal rat and human plasma. 15, 16 In some previous studies of isolated myocytes 2 and cultured myocytes, 17 the ANP concentrations that displayed negative inotropic effects 2, 17 and induced maximum cGMP levels in myocyte suspension 18 were also higher and similar to the ANP levels found in our study. In addition, ANP concentration adjacent to myocytes in vivo may be markedly higher in the presence of local tissue autocrine and paracrine release. 19 The effects of ANP on intracellular Ca 2ϩ are controversial. 20, 21 We observed that ANP has no effect on net Ca 2ϩ homeostasis, as reported by the [Ca 2ϩ ] i transient in contracting normal adult myocytes. In contrast, we found that the acute depression of contractility by ANP is mediated in part by intracellular acidification. Intracellular acidification is well established as a mechanism that depresses myofilament sensitivity to [Ca 2ϩ ] i and causes reductions in tension development and contraction amplitude. 7, 8 We previously reported that nitric oxide donors and 8-bromo-cGMP (cGMP analogue) cause both depression of myocyte contractility and intracellular acidification by disabling forward Na ϩ /H ϩ exchange. 13 Because cGMP has been shown to be the major second messenger of ANP, 1-3 our data are consistent with the notion that ANP directly causes intracellular acidification via cGMP signaling by disabling forward Na ϩ /H ϩ exchange. Our observations of the acute effects of ANP on contractility and pH i do not exclude the potential of other intracellular effects mediating changes in contractility, particularly during long-term exposure.
In this study, we also make the novel observation that ANP does not modify myocyte contractility or promote intracellular acidification in hypertrophied myocytes, in contrast to normal myocytes. Our data and findings of others in the kidney and vasculature 22, 23 suggest that expected physiological responses to ANP are blunted or abolished in the presence of chronic upregulation of local tissue or plasma ANP. In this study, we observed that the cGMP levels are upregulated in hypertrophied LV, which is consistent with previous observations in mechanically overloaded hypertrophied heart models. 24, 25 In our previous study, we showed in hypertrophied myocytes that the direct challenge of 8-bromo-cGMP did not cause either the depression of contraction or intracellular acidification that was observed in normal myocytes. 13 Conversely, we have shown that the basal Na ϩ /H ϩ exchanger activity measured by the recovery from NH 4 Cl-induced intracellular acidosis is similar in control and hypertrophied myocytes. 12 In the present study, we showed that expression of Na ϩ /H ϩ exchanger is similar in control and hypertrophied myocytes. Taken together, these data strongly suggest that basal Na ϩ /H ϩ exchanger expression and activity are preserved in compensatory hypertrophy, whereas the downstream coupling of cGMP to Na ϩ /H ϩ exchanger is altered in hypertrophied myocytes in the presence of chronic elevation of LV cGMP levels. The mechanism of absence of ANP effects on hypertrophied myocytes might be the inhibition of Na ϩ /H ϩ exchanger activity by phosphorylation of its associated protein by cGMP-activated protein kinase G 26 or suppressed activity of protein kinase G by its translocation. Further studies are needed to clarify the downstream exchanger regulation by cGMP using in vitro cell models and to examine the interplay with other signaling pathways.
Both ANP and brain natriuretic peptide (BNP) are currently under investigation as therapeutic agents for the treatment of patients with heart failure. A major concern is the potential for stimulation of the ANP-cGMP pathway to further depress LV contractility. Our data suggest that the capacity for ANP to acutely depress contractility is blunted or absent in myocytes with pathological hypertrophy. In addition, both ANP and nitric oxide have the potential to negatively modulate pathological growth of myocardial and smooth muscle cells 27, 28 and to compete with the effects of angiotensin II and other growth factors whose actions are mediated in part by stimulation of Na ϩ /H ϩ exchange and intracellular alkalinization. 29, 30 The present study suggests that this physiological pH-mediated regulation of growth by ANP and other cGMP signaling molecules may be altered in pathological hypertrophy.
In summary, we report that intracellular acidification contributes to the immediate negative inotropic effects of ANP in normal adult myocytes. This effect of ANP on intracellular pH regulation and contractility is absent in hypertrophied myocytes. Further study is needed to elucidate the molecular regulation of ANP induction and its signaling in pathological hypertrophy.
